Research Trial

Astellas Pharma Protocol 905-UC-050 - This study may help reduce urinary frequency and incontinence associated with robotic prostate surgery.

Some Requirements:

• Subject has not used any medications for overactive bladder for 14 days prior to enrollment.

Sponsored by: Astellas Pharma
Length of Study: 15 weeks
Enrollment: Open

Please contact one of our Clinical Research Coordinators today to find out more information if you are interested in this trial.

Tonya Godfrey, R.N., Clinical Research Coordinator (315) 706-8112
Mark Chilton, Clinical Research Coordinator (315) 396-1729
Melissa Clark, R.N., Clinical Research Coordinator (315) 363-9523 

Our Principal Investigators are: David M. Albala, M.D., Joel S. Bass, M.D., Bashar Omarbasha, M.D.